Strategic Wealth Partners Ltd. decreased its stake in AmerisourceBergen Corp. (NYSE:ABC) by 36.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,660 shares of the company’s stock after selling 948 shares during the quarter. Strategic Wealth Partners Ltd.’s holdings in AmerisourceBergen were worth $141,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in the business. Alpha Windward LLC increased its holdings in shares of AmerisourceBergen by 6.6% in the second quarter. Alpha Windward LLC now owns 1,845 shares of the company’s stock worth $161,000 after acquiring an additional 114 shares in the last quarter. Capital Wealth Planning LLC increased its holdings in shares of AmerisourceBergen by 1.1% in the second quarter. Capital Wealth Planning LLC now owns 10,236 shares of the company’s stock worth $873,000 after acquiring an additional 115 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. increased its holdings in shares of AmerisourceBergen by 1.1% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 12,424 shares of the company’s stock worth $988,000 after acquiring an additional 138 shares in the last quarter. Rothschild Investment Corp IL increased its holdings in shares of AmerisourceBergen by 1.1% in the second quarter. Rothschild Investment Corp IL now owns 12,345 shares of the company’s stock worth $1,053,000 after acquiring an additional 140 shares in the last quarter. Finally, Hartford Investment Management Co. increased its holdings in shares of AmerisourceBergen by 0.8% in the second quarter. Hartford Investment Management Co. now owns 18,286 shares of the company’s stock worth $1,559,000 after acquiring an additional 151 shares in the last quarter. 65.03% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NYSE:ABC traded down $2.01 during mid-day trading on Friday, reaching $83.54. 951,189 shares of the stock were exchanged, compared to its average volume of 1,435,938. The company has a quick ratio of 0.56, a current ratio of 0.95 and a debt-to-equity ratio of 1.40. The company has a market cap of $17.98 billion, a P/E ratio of 12.87, a P/E/G ratio of 1.53 and a beta of 0.97. AmerisourceBergen Corp. has a one year low of $69.36 and a one year high of $94.85. The stock’s 50 day simple moving average is $87.53 and its 200-day simple moving average is $82.13.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 3rd. Investors of record on Monday, August 19th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, August 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.92%. AmerisourceBergen’s payout ratio is presently 24.65%.
Several equities research analysts have issued reports on the company. Zacks Investment Research upgraded AmerisourceBergen from a “hold” rating to a “buy” rating and set a $89.00 price target for the company in a report on Wednesday, June 12th. Argus lowered their price target on AmerisourceBergen from $115.00 to $100.00 and set a “buy” rating for the company in a report on Monday, June 3rd. TheStreet upgraded AmerisourceBergen from a “c+” rating to a “b” rating in a report on Thursday, August 1st. Finally, ValuEngine downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Tuesday, August 6th. Two analysts have rated the stock with a sell rating, five have given a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $88.00.
In other AmerisourceBergen news, Chairman Steven H. Collis sold 107,826 shares of the firm’s stock in a transaction that occurred on Wednesday, June 19th. The stock was sold at an average price of $86.18, for a total value of $9,292,444.68. Following the completion of the transaction, the chairman now directly owns 242,405 shares in the company, valued at $20,890,462.90. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider John G. Chou sold 13,997 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $89.58, for a total value of $1,253,851.26. Following the completion of the transaction, the insider now owns 65,782 shares of the company’s stock, valued at $5,892,751.56. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 185,336 shares of company stock valued at $16,014,325. 27.80% of the stock is owned by corporate insiders.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Recommended Story: Do equity income investments outperform growth and income investments?
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.